Alexander
Boiko at the University of California Irvine has discovered a new way to fight
against melanomas. Melanoma is the most lethal type of skin cancer and can also
metastasize very easily. He did this by blocking CD47, which is a cell surface
protein on melanin cells, since this will increase the amount the cells were
phagocytosed by macrophages. The term phagocytosed is referred to in the paper
as “eaten,” and macrophages are a part of the innate immune system and act as
phagocytic cells. Another surface protein, CD271, was also found to be important
when used with the CD47. CD271 was used in order to target the most aggressive
melanoma cells selectively.
In order
for the CD47 to not be eliminated by the immune system, CD47 was overexpressed
by metastatic melanomas. To have better results they decided that both proteins
needed to be overexpressed in order to trick the immune system so that it could
spread to other parts of the body. They found that by blocking of CD47 and
targeting of CD271 metastases was stopped in human melanoma tumors that were
put in mice. One thing to take note of is that there was major alteration of
the microenvironment surrounding the tumors, which helped with the positive
results.
Before this
could be done on humans, further research needs to be done in order to see if
the combination of CD47 and CD271 can be safely used. But Boiko is hopeful that
with the combination of this new therapy as well as other treatments emerging that
positive outcomes in the fight against metastatic melanomas will arise.
http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30890-7